Market Research Hub

New Report Offers Pipeline Analysis and Insights on Alpha Galactosidase a Enzyme for H2 2017


Albany, NY -- (SBWIRE) -- 11/13/2017 -- Market Research Hub has included a new report in its database titled 'Alpha Galactosidase A (Alpha D-Galactosidase A or Alpha D Galactoside Galactohydrolase or Melibiase or Agalsidase or GLA or EC - Pipeline Review, H2 2017'. This report gives a comprehensive view of the alpha galactosidase A enzyme details, with a prime focus on its targeted therapeutics, analysis by indications, mechanism of action (MoA), stage of development, route of administration (RoA) and molecule type.

Request Free Sample Report:

Alpha Galactosidase is used for Prevention of gas, Bloating, and discomfort and other conditions. In this study, the report provides a snapshot of the global therapeutic landscape for Alpha Galactosidase A along with analysis on pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages.

The report starts by defining the overview of Alpha Galactosidase A, which is a glycoside hydrolase enzyme encoded by the GLA gene. This enzyme is a homodimeric glycoprotein that hydrolyzes the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. Mutations in this gene affect the synthesis and stability of this enzyme which causes Fabry's disease. In this disease, Alpha-galactosidase A, which normally breaks down a fatty substance called globotriaosylceramide (Gb3), is missing or does not function properly.

Scope of the Report

The pipeline study covers products from therapy areas Genetic Disorders which include indications Fabry Disease. This report provides a detailed view of the drug development in the targeted therapeutic landscape. Information from various companies, research institutes and universities has been gathered in order to compile this report with respect to industry-specific sources. Development of drugs are based on various developmental stages ranging from pre-registration, undisclosed stage and discovery stage is covered. Drug profiles for the products in the pipeline that comprises descriptive licensing and collaboration details and product description are also included in this report.

Browse Full Report with TOC-

Competitive Landscape

This report also aids in getting a competitive advantage by identifying and following emerging companies in the market along with their portfolios that help in effective decision making and to develop counter strategies with respect to a particular company. At present, companies involved in therapeutics development include Pharming Group NV, Amicus Therapeutics Inc., Sangamo Therapeutics Inc., Greenovation Biotech GmbH, Shire Plc, iBio Inc., Protalix BioTherapeutics Inc and JCR Pharmaceuticals Co. Ltd.

The information in this report is sourced from exclusive databases, specific websites of universities and companies, conferences, presentation of investors, clinical trial registries and SEC filings. Also, featured press releases from the websites of companies and universities and third-party sources that are specific to this particular industry have been used in order to gather information presented in this report. In addition, care has been taken to ensure that only the latest developments are captured in the report on a real-time basis.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -